WHO ICTRP trial
Feasibility study of adjuvant chemotherapy with nanoparticle albumin-bound…
JPRN-UMIN000011215 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000011215 |
|---|---|
| Public title | Feasibility study of adjuvant chemotherapy with nanoparticle albumin-bound (nab)- paclitaxel and carboplatin in patients with completely resected pathological IB non small cell lung cancer |
| Scientific title | Feasibility study of adjuvant chemotherapy with nanoparticle albumin-bound (nab)- paclitaxel and carboplatin in patients with completely resected pathological IB non small cell lung cancer - Feasibility study of adjuvant chemotherapy with nanoparticle albumin-bound (nab)- paclitaxel and carboplatin… |
| Primary sponsor | Department of Thoracic Surgery , Faculty of Life Science Kumamoto University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Non-small cell lung cancer |
| Interventions | Nab-paclitaxel 100mg/m2 on day 1,8,15 Carboplatin AUC6 q3weeks , 4 cycles. |
| Registration date | Jul 18, 2013 |
| Target size | 35 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: